Item 1.01 Entry Into a
Material Agreement
On December 8, 2022,
7GC & Co. Holdings Inc., a Delaware corporation (“7GC”), entered into an Agreement and Plan of Merger and Reorganization
(the “Merger Agreement”), by and among Banzai International Inc., a Delaware corporation (the “Company”),
7GC, 7GC Merger Sub I, Inc., a Delaware corporation and an indirect wholly owned subsidiary of 7GC (“First Merger Sub”),
and 7GC Merger Sub II, LLC, a Delaware limited liability company and a direct wholly owned subsidiary of 7GC (“Second Merger
Sub” and, together with First Merger Sub, the “Merger Subs” and each, a “Merger Sub”).
Pursuant to the terms of
the Merger Agreement, the parties thereto will enter into a business combination transaction (the “Business Combination”
and together with the other transactions contemplated by the Merger Agreement, the “Transactions”), pursuant to which,
among other things, (i) First Merger Sub will merge with and into the Company (the “First Merger”), with the Company
surviving as an indirect wholly owned subsidiary of 7GC (the “Surviving Corporation”), and, (ii) immediately following
the First Merger, the Surviving Corporation will merged with and into Second Merger Sub (the “Second Merger” and, together
with the First Merger, the “Mergers”), with the Second Merger Sub surviving the Second Merger as a wholly owned subsidiary
of 7GC. At the closing of the Transactions (the “Closing”), 7GC will change its name to Banzai International, Inc.,
and its common stock is expected to be listed on the Nasdaq Capital Market (“NASDAQ”).
The Business Combination
is expected to be consummated after the required approval by the stockholders of 7GC and the satisfaction of certain other conditions
summarized below.
Merger Agreement
Consideration Paid to the Company; Effects of the Mergers
The Business Combination
values the combined company resulting from the completion of the Business Combination at a pro forma enterprise value of approximately
$380 million. Under the terms of the Merger Agreement, the consideration to be paid to security holders of the Company prior to the
First Effective Time (the “Pre-Closing Holders”) in the First Merger is $293,000,000, subject to certain adjustments
contained in the Merger Agreement, including a reduction of $7,672,000 and addition of the 7GC Transaction Expenses (as defined in the
Merger Agreement) in excess of the deferred underwriting fees from 7GC’s initial public offering and $10,000,000, in each case as
more specifically set forth in the Merger Agreement. The consideration will be paid in stock, comprised of shares of 7GC’s Class
A common stock, par value $0.0001 per share (the “7GC New Class A Shares”), which will have one vote per share, and
7GC’s Class B common stock, par value $0.0001 per share (the “7GC New Class B Shares”), which will have ten votes
per share, in each case, as such classes of common stock exist as of immediately following the First Effective Time (as defined below),
and in cash in lieu of any fractional 7GC New Class A Shares or 7GC New Class B Shares that would otherwise be owed to any Pre-Closing
Holder, as well as restricted 7GC New Class A Shares subject to the vesting and forfeiture provisions provided for in the Merger Agreement
and described under “Earn Out Shares” below (collectively, the “Earn Out Shares”).
At the effective time of
the First Merger (the “First Effective Time”), each outstanding share of Class A common stock of the Company (the “Company
Class A Common Stock”) and each outstanding share of Class B common stock of the Company (the “Company Class B Common
Stock”) (in each case other than dissenting shares and any shares held in the treasury of the Company) shall be cancelled and
converted into the right to receive (A) a number of 7GC New Class A Shares or 7GC New Class B Shares, respectively, equal to (x) the Per
Share Value (as defined below) divided by (y) $10.00 (the “Exchange Ratio”), plus (B) the right to receive the
Earn Out Shares, as determined pursuant to the terms of the Merger Agreement and described under “Earn Out Shares” below.
“Per Share Value”
equals (i) an amount equal to (A) $293,000,000, payable in 7GC New Class A Shares or 7GC New Class B Shares, as applicable (the “Total
Consideration”), less (B) $7,672,000, plus (C) the amount (which shall in no event be less than $0) of (x) 7GC
Transaction Expenses (as defined in the Merger Agreement) as of 12:01 a.m. Pacific Time on the date of Closing minus (y) deferred
underwriting fees in the amount of $8,050,000 in connection with 7GC’s initial public offering minus (z) $10,000,000 divided
by (ii) (A) the total number of shares of Company Class A Common Stock and Company Class B Common Stock issued and outstanding as
of immediately prior to the First Effective Time, (B) the maximum aggregate number of shares of Company Class A Common Stock issuable
upon full exercise of options of the Company to purchase Company Class A Common Stock (the “Company Options”) issued,
outstanding and vested immediately prior to the First Effective Time, (C) the maximum aggregate number of shares of Company Class A Common
Stock issuable upon conversion of Conversion Amount (as defined in the Merger Agreement) under each Senior Convertible Note (as defined
in the Merger Agreement) as of immediately prior to the First Effective Time at the applicable Senior Convertible Note Conversion Price
(as defined in the Merger Agreement) and (D) the maximum aggregate number of shares of Company Class A Common Stock issuable upon conversion
of the Outstanding Amount (as defined in the Merger Agreement) under each Subordinated Convertible Note (as defined in the Merger Agreement)
as of immediately prior to the First Effective Time at the applicable Subordinated Convertible Note Conversion Price (as defined in the
Merger Agreement).
On the terms and subject
to the conditions set forth in the Merger Agreement, at the effective time of the Second Merger (the “Second Effective Time”),
each share of common stock of the Surviving Corporation issued and outstanding immediately prior to the Second Effective Time shall be
cancelled and no consideration shall be delivered therefor.
Treatment of Outstanding
Equity Awards
In addition, as of the First
Effective Time: (i) (A) each Company Option, whether vested or unvested, that is outstanding immediately prior to the First Effective
Time and held by a Pre-Closing Holder who is providing services to the Company immediately prior to the First Effective Time (a “Pre-Closing
Holder Service Provider”), will be assumed and converted into an option (a “7GC Option”) with respect to
a number of 7GC New Class A Shares calculated in the manner set forth in the Merger Agreement, and (B) immediately prior to the First
Effective Time, each Pre-Closing Holder Service Provider who holds a vested Company Option will receive, in exchange for such vested Company
Option, such Pre-Closing Holder Service Provider’s allocation of the Earn Out Shares, as determined pursuant to the terms of the
Merger Agreement; and (ii) (A) the vested portion of each Company Option that is outstanding at such time and held by a Pre-Closing Holder
who is not then providing services to the Company (a “Pre-Closing Holder Non-Service Provider”) will be assumed and
converted into a 7GC Option with respect to a number of 7GC New Class A Shares calculated in the manner set forth in the Merger Agreement,
and (B) immediately prior to the First Effective Time, each Pre-Closing Holder Non-Service Provider who holds a vested and exercisable
Company Option will receive, in exchange for such Company Option, such Pre-Closing Holder’s allocation of the Earn Out Shares, as
determined pursuant to the terms of the Merger Agreement.
Treatment of SAFE Rights
As of the First Effective
Time, each right to receive a portion of the Total Consideration pursuant to certain Company Simple Agreements for Future Equity (each,
a “Safe Agreement”) (each, a “SAFE Right”) that is outstanding immediately prior to the First Effective
Time shall be cancelled and converted into and become (i) the right to receive a number of 7GC New Class A Shares equal to the Cash-Out
Amount (as defined in the applicable SAFE Agreement that governs such SAFE Right) in respect of such SAFE Right divided by $10.00,
plus (ii) the right to receive the Earn Out Shares, as determined pursuant to the terms of the Merger Agreement.
Treatment of Convertible
Notes
As of the
First Effective Time, (i) each Subordinated Convertible Note that is outstanding immediately prior to the First Effective Time will
be cancelled and converted into and become (A) the right to receive a number of 7GC New Class A Shares equal to (1) the Outstanding Amount
in respect of such Subordinated Convertible Note divided by the Subordinated Convertible Note Conversion Price in respect of such
Subordinated Convertible Note, multiplied by (2) the Exchange Ratio, plus (B) the right to receive the Earn Out
Shares, as determined pursuant to the terms of the Merger Agreement, and (ii) each Senior Convertible Note that is outstanding immediately
prior to the First Effective Time will be cancelled and converted into and become (A) the right to receive a number of 7GC New Class A
Shares equal to (1) the Conversion Amount in respect of such Senior Convertible Note, multiplied by (2) the Exchange Ratio, plus
(B) the right to receive the Earn Out Shares, as determined pursuant to the terms of the Merger Agreement.
Earn Out Shares
At the First Effective Time,
in accordance with an allocation schedule to be provided by the Company (the “Allocation Schedule”) prior to the Closing,
7GC will also issue or cause to be issued to each Pre-Closing Holder, such Pre-Closing Holder’s proportionate allocation (based
on such Pre-Closing Holder’s Closing Merger Consideration) of the Earn Out Shares. The Earn Out Shares will vest upon the occurrence
of the following triggering events: (i) 1,950,000 of the Earn Out Shares will vest if the closing price on NASDAQ (the “Closing
Price”) of a 7GC New Class A Share is greater than or equal to $12.00 over any twenty (20) trading days within any thirty (30)
consecutive trading day period; (ii) 1,950,000 of the Earn Out Shares will vest if the Closing Price of the 7GC New Class A Shares is
greater than or equal to $14.00 over any twenty (20) trading days within any thirty (30) consecutive trading day period, and (iii) 1,950,000
of the Earn Out Shares will vest if the Closing Price of the 7GC New Class A Shares is greater than or equal to $16.00 over any twenty
(20) trading days within any thirty (30) consecutive trading day period, in each case, prior to the expiry of sixty (60) months following
the Closing (the “Earn Out Period”). In addition, if there is a sale of 7GC after the Closing and prior to the expiration
of the Earn Out Period that will result in the holders of 7GC New Class A Shares receiving a price per share equal to or in excess of
the applicable price per share thresholds described above, the Earn Out Shares will vest in connection with such sale of the Company in
the manner set forth in the Merger Agreement. If the applicable triggering event has not occurred prior to the expiration of the Earn
Out Period, then all Earn Out Shares which would vest in connection with such triggering event will be automatically forfeited and deemed
transferred to 7GC and will be cancelled by 7GC and cease to exist.
Representations and Warranties
The Merger Agreement contains
customary representations and warranties of the parties thereto with respect to, among other things, (i) entity organization, formation
and qualification, (ii) authorization to enter into the Merger Agreement, (iii) capital structure, (iv) consents and approvals, (v) financial
statements, (vi) liabilities, (vii) permits, (viii) litigation, (ix) material contracts, (x) tax matters, (xi) intellectual property,
(xii) absence of changes, (xiii) environmental matters, (xiv) employee matters, (xv) compliance with applicable laws, (xvi) regulatory
matters, (xvii) labor matters, (xviii) benefit plans, (xix) insurance, (xx) real and personal property, (xxi) brokers, (xxii) transactions
with affiliates, (xxiii) data privacy and security requirements, (xxiv) compliance with international trade and anti-corruption laws and
(xxv) indebtedness. The representations and warranties of the parties contained in the Merger Agreement will terminate and be of no further
force and effect as of the Closing.
Covenants
The
Merger Agreement contains customary covenants of the parties thereto, including, among others, covenants providing for: (i) the operation
of the Company and its subsidiaries’ (including Hyros Inc., a Delaware corporation (“Hyros”), but prior to the
closing of the Hyros Acquisition (as defined below), only to the extent the Company or any of its affiliates exercises control) respective
businesses in the ordinary course of business prior to consummation of the Transactions; (ii) the parties’ efforts to satisfy conditions
to consummate the Transactions; (iii) 7GC’s access to books and records of the Company and its subsidiaries; (iv) restrictions
on public announcements or press releases with respect to the Transactions; (v) the preparation and filing (after delivery to 7GC of
certain of the Company’s financial statements audited in accordance with the standards of PCAOB (the “PCAOB Financials”)
on or prior to March 15, 2023) of a registration statement on Form S-4 and containing a proxy statement of 7GC (the “Registration
Statement/Proxy Statement”) in connection with the registration under the Securities Act of 1933, as amended (the “Securities
Act”), of the 7GC New Class A Shares and 7GC New Class B Shares to be issued pursuant to the Merger Agreement, which will also
contain a prospectus and proxy statement included for the purpose of soliciting proxies from 7GC’s stockholders to vote in favor
of certain matters (the “7GC Stockholder Matters”), including the (1) adoption and approval of the Merger Agreement
and approval of the Transactions, (2) approval of the Mergers, (3) approval of the issuance of the 7GC New Class A Shares and the 7GC
New Class B Shares and the Earn Out Shares, (4) adoption and approval of an equity incentive plan, (5) adoption and approval of an employee
stock purchase plan, (6) adoption and approval of the second amended and restated certificate of incorporation of 7GC, (7) designation
by 7GC of Jack Leeney as a director on the 7GC board of directors (the “Board”) effective as of the Closing and Joe
Davy, Mitch Kitamura and four additional individuals designated by the Company as directors on the Board effective
as of the Closing and designation of the classes of the Board, (8) adoption and approval of any other proposals as either the Securities
and Exchange Commission (the “SEC”) or NASDAQ may indicate are necessary in its comments to the Registration Statement/Proxy
Statement and (9) adjournment of the 7GC meeting of stockholders, if necessary, to permit further solicitation of proxies because there
are not sufficient votes to approve and adopt any of the foregoing; (vi) the Company’s reasonable best efforts to take all actions
and do all things necessary, proper or advisable to consummate the transactions contemplated by that certain Share Purchase Agreement,
by and among the Company, GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (collectively, “GEM”) dated as of
May 27, 2022 (the “GEM Agreement”), (vii) protection of, and access to, confidential information of the parties, (viii)
the Company and 7GC’s efforts to obtain a listing of the 7GC New Class A Shares on NASDAQ and (ix) the parties’ efforts to
obtain necessary approvals from governmental agencies. Under the GEM Agreement, GEM has agreed to purchase from the Company (or its successor
following a merger transaction) up to a number of duly authorized, validly issued, fully paid and non-assessable shares of Company common
stock having an aggregate value of $100,000,000.
Conditions to Closing
The consummation of the
Transactions is subject to customary closing conditions for transactions involving special purpose acquisition companies, including, among
others: (i) approval of the 7GC Stockholder Matters by 7GC’s stockholders, (ii) the expiration or termination of the waiting period
under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (iii) no order, statute, rule or regulation enjoining or prohibiting
the consummation of the Transactions being in force, (iv) the Registration Statement/Proxy Statement having become effective, (v) the
7GC New Class A Shares (including the Earn Out Shares) to be issued pursuant to the Merger Agreement having been approved for listing
on NASDAQ, (vi) 7GC having at least $5,000,001 of net tangible assets remaining after redemptions by 7GC stockholders, (vii) consummation
of the acquisition by the Company of Hyros, pursuant to the terms and subject to the conditions set forth in that certain Agreement and
Plan of Merger, dated as of December 8, 2022 (the “Hyros Purchase Agreement”), by and among the Company, Hero Merger
Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of the Company (the “Hyros Merger Sub”), Hyros
and the stockholder representative party thereto (the “Stockholder Representative”), and (vii) customary bring-down
conditions. Additionally, the obligations of the Company and its subsidiaries to consummate the Transactions are also conditioned upon,
among others, (A) 7GC having delivered to the Company executed copies of the Registration Rights Agreement (as defined below) and the
Exchange Agent Agreement (as defined in the Merger Agreement), and evidence that the second amended and restated certificate of incorporation
of 7GC has been filed with the Secretary of State of Delaware, and (B) the sum of (i) the cash proceeds to be received by 7GC at Closing
from the trust account established by 7GC in connection with the Transactions (after, for the avoidance of doubt, giving effect to redemptions
by 7GC stockholders), (ii) the $100,000,000 equity commitment by GEM under the GEM Agreement and (iii) the unrestricted cash on the balance
sheet of the Company as of immediately prior to the Closing equaling or exceeding $100,000,000.
Termination
The Merger Agreement may be terminated as follows:
| (i) | by mutual written consent of Company and 7GC; |
| (ii) | prior to the Closing, by written notice to the Company from 7GC if (i) there is any breach of any representation,
warranty, covenant or agreement on the part of the Company set forth in the Merger Agreement, such that certain closing conditions would
not be satisfied at the Closing, subject to a 30-day cure period, (ii) the Closing has not occurred on or before June 8, 2023
(the “Termination Date”), subject to certain conditions set forth in the Merger Agreement, (iii) the consummation of
the Mergers is permanently enjoined or prohibited by the terms of a final, non-appealable governmental order or a statute, rule or regulation,
or (iv) the 7GC Stockholder Matters are not approved by the 7GC stockholders at the special meeting (subject to any adjournment, postponement
or recess of the meeting); |
| (iii) | prior
to the Closing, by written notice to 7GC from the Company if (i) there is any breach of any representation, warranty, covenant or agreement
on the part of 7GC set forth in the Merger Agreement, such that certain closing conditions would not be satisfied at the Closing, subject
to a 30-day cure period, (ii) the Closing has not occurred on or before the Termination Date, subject to certain conditions set forth
in the Merger Agreement, (iii) the consummation of the Mergers is permanently enjoined or prohibited by the terms of a final, non-appealable
governmental order or a statute, rule or regulation, or (iv) the 7GC Stockholder Matters are not approved by the 7GC stockholders at
the special meeting (subject to any adjournment, postponement or recess of the meeting); |
| (iv) | by written notice from 7GC to the Company if the Company fails to deliver to 7GC the written consents
of the equityholders of the Company constituting the Required Company Stockholder Approval (as defined in the Merger Agreement) consenting
to the terms of the Merger Agreement and approving the Transactions within 5 Business Days after the Registration Statement/Proxy Statement
is declared effective by the SEC; or |
| (v) | by written notice from 7GC to the Company if the PCAOB Financials have not been delivered to 7GC in accordance
with the Merger Agreement on or prior to March 15, 2023. |
The foregoing
description of the Merger Agreement and the Transactions does not purport to be complete and is qualified in its entirety by the terms
and conditions of the Merger Agreement and any related agreements. The Merger Agreement has been included as an exhibit to this Current
Report on Form 8-K (this “Current Report”) to provide investors with information regarding its terms. It is not intended
to provide any other factual information about 7GC, the Company or any other party to the Merger Agreement or any related agreement. In
particular, the representations, warranties, covenants and agreements contained in the Merger Agreement, which were made only for purposes
of such agreement and as of specific dates, were solely for the benefit of the parties to the Merger Agreement, are subject to limitations
agreed upon by the contracting parties (including being qualified by confidential disclosures made for the purposes of allocating contractual
risk between the parties to the Merger Agreement instead of establishing these matters as facts) and are subject to standards of materiality
applicable to the contracting parties that may differ from those applicable to investors and security holders. Investors and security
holders are not third-party beneficiaries under the Merger Agreement and should not rely on the representations, warranties, covenants
and agreements, or any descriptions thereof, as characterizations of the actual state of facts or condition of any party to the Merger
Agreement. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the
Merger Agreement, which subsequent information may or may not be fully reflected in 7GC’s public disclosures.
A copy of
the Merger Agreement is filed with this Current Report as Exhibit 2.1 and is incorporated herein by reference, and the foregoing description
of the Merger Agreement is qualified in its entirety by reference thereto.
Certain Related Agreements
Hyros Purchase Agreement
Prior to
the execution and delivery of the Merger Agreement, on December 8, 2022, the Company entered into the Hyros Purchase Agreement. Pursuant
to the terms of the Hyros Purchase Agreement, Hyros Merger Sub will be merged with and into Hyros and shall continue as the surviving
company and as a wholly owned subsidiary of the Company (the “Hyros Acquisition”). The Closing of the Business Combination
and the Transactions is conditioned on the consummation of the Hyros Acquisition. The aggregate consideration to be paid by the Company
shall be an amount equal to (a) $110,000,000 plus (b) if any, an amount equal to (i) $2,500,000 multiplied by (ii) an amount
equal to (A) (x) the amount of the annual recurring revenue of Hyros calculated as of the closing of the Hyros Acquisition minus
(y) the amount of the annual recurring revenue of Hyros calculated as of November 30, 2022 divided by (B) $600,000, subject to
certain adjustments contained in the Hyros Purchase Agreement, including deductions for working capital, indebtedness, and certain unpaid
third-party expenses.
For a period
of 90 days following the closing date of the Hyros Acquisition, and after consummation of the Business Combination, if 7GC reasonably
determines that it has sufficient cash on its balance sheet, after taking into account all then-outstanding liabilities of 7GC (including
any liabilities incurred by or on behalf of 7GC and its affiliates in connection with the Business Combination), then the Stockholder
Representative will have the right to require that 7GC redeem, from each Hyros stockholder who received shares of Banzai common stock
at the closing of the Hyros Acquisition and then 7GC New Class A Shares as a Pre-Closing Holder at the Closing, a number of shares of
7GC up to a specified maximum per stockholder for payment of an amount in cash calculated in accordance with the Hyros Purchase Agreement.
The maximum aggregate cash amount that could be payable by 7GC in connection with such a redemption is expected to be approximately $86.9
million, subject to adjustment for any adjustments made at closing to cash, working capital, and other components of aggregate consideration
under, and in each case calculated in accordance with the terms of, the Hyros Purchase Agreement. Any such redeemed shares will be deemed
forfeited by the redeeming stockholder and cancelled by 7GC. The Hyros Purchase Agreement contains customary representations and warranties
of the parties thereto, which survive for two years following the closing of the Hyros Acquisition. The consummation of the transactions
contemplated by the Hyros Purchase Agreement (the “Hyros Transactions”) is subject to customary closing conditions,
including (i) approval of the Hyros Transactions by (A) the holders of a majority of the shares of Hyros’ common stock and (B) the
holders of a majority of the shares of the Company’s capital stock, (ii) the expiration or termination of the waiting period under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and (iii) no order, statute, rule or regulation enjoining or prohibiting
the consummation of the Hyros Transactions being in force.
Sponsor Support Agreement
Concurrently
with the execution and delivery of the Merger Agreement, 7GC, the Company, 7GC & Co. Holdings LLC, a Delaware limited liability company
(the “Sponsor”), and the other stockholders of 7GC set forth on Schedule I of the Sponsor Support Agreement (such individuals,
together with Sponsor, each a “Stockholder”, and collectively, the “Stockholders”) entered into
a Voting and Support Agreement (the “Sponsor Support Agreement”), pursuant to which, among other things, each Stockholder
agreed to vote or consent, in person or by proxy, all of its Subject Shares (as defined in the Sponsor Support Agreement) (a) in favor
of the adoption of the Merger Agreement and approval of the Transactions, (b) against any action, proposal, transaction or agreement that
would result in a breach in any respect of any representation, warranty, covenant, obligation or agreement of 7GC or Merger Subs contained
in the Merger Agreement, (c) in favor of the proposals set forth in the Registration Statement/Proxy Statement, and (d) except
as set forth in the Registration Statement/Proxy Statement, against the following actions or proposals: (i) any proposal in opposition
to approval of the Merger Agreement or in competition with or materially inconsistent with the Merger Agreement; or (ii) (A)
any amendment of the certificate of incorporation or bylaws of 7GC; (B) any change in 7GC’s corporate structure or business;
or (C) any other action or proposal involving 7GC or any of its subsidiaries that is intended, or would reasonably be expected, to
prevent, impede, interfere with, delay, postpone or adversely affect the Transactions in any material respect or would reasonably be expected
to result in any of 7GC’s closing conditions or obligations under the Merger Agreement not being satisfied. Additionally, each of
the Stockholders agreed not to, and shall cause its affiliates not to, enter into any agreement, commitment or arrangement with any person,
the effect of which would be inconsistent with or violative of the foregoing.
The foregoing
description of the Sponsor Support Agreement is not complete and is qualified in its entirety by reference to the Sponsor Support Agreement,
which is filed as Exhibit 10.1 to this Current Report and incorporated herein by reference.
Company Support Agreement
Concurrently
with the execution and delivery of the Merger Agreement, 7GC entered into a Company Support Agreement (the “Company Support Agreement”),
with the Company and certain stockholders of the Company set forth on Schedule I thereto (each a “Company Stockholder”
and, collectively, the “Company Stockholders”), pursuant to which, among other things, each Company Stockholder agrees
not to (i) sell, assign, offer, exchange, transfer, pledge, dispose of, permit to exist any lien, security interest, or similar encumbrance
with respect to, or otherwise encumber, any of the shares held by Company Stockholders set forth on Schedule I thereto (the “Subject
Shares”) , (ii) deposit any Subject Shares into a voting trust or enter into a voting agreement or arrangement or grant any
proxy or power or attorney with respect thereto that is inconsistent with the Company Support Agreement, (iii) enter into any contract,
option or other arrangement or undertaking with respect to the direct or indirect acquisition or sale, assignment, transfer or other disposition
of the Subject Shares or (iv) take any action that would have the effect of preventing, impeding, interfering or adversely affecting such
Company Stockholders’ ability to perform its obligations under the Company Support Agreement. Additionally, each Company Stockholder,
during the period commencing on the date of the Support Agreement until the Closing or termination of the Merger Agreement, agrees that,
at any meeting of the stockholders of the Company, and in any action by written consent of the stockholders of the Company, such Company
Stockholder will, if a meeting is held, appear at the meeting and vote or provide consent, in person or by proxy, all of its, his or her
Subject Shares: (a) to approve and adopt the Merger Agreement and the Transactions; (b) in any other circumstances upon which a consent
or other approval is required under the governing documents of the Company or the Company stockholder agreements or otherwise sought with
respect to, or in connection with, the Merger Agreement or the Transactions, to vote, consent or approve (or cause to be voted, consented
or approved) with respect to all of such Company Stockholder’s Subject Shares held at such time in favor thereof; and (c) against
any 7GC Competing Transaction (as defined in the Merger Agreement) or any proposal, action or agreement that would impede, interfere,
frustrate, delay, postpone, prevent or nullify any provision of the Company Support Agreement, the Merger Agreement or the Mergers.
The foregoing
description of the Company Support Agreement is not complete and is qualified in its entirety by reference to the Company Support Agreement,
which is filed as Exhibit 10.2 to this Current Report and incorporated herein by reference.
Registration
Rights Agreement
At the Closing,
7GC, the Sponsor and certain stockholders of the Company (such stockholders and the Sponsor, collectively, the “Holders”)
will amend and restate the Registration Rights Agreement, dated as of December 22, 2020, between 7GC and the Sponsor (such amended and
restated agreement, the “Registration Rights Agreement”). The Registration Rights Agreement will provide the Holders
(and their permitted transferees) with the right to require 7GC, at 7GC expense, to register the securities of 7GC that they hold on customary
terms for a transaction of this type, including customary demand and piggyback registration rights. The Registration Rights Agreement
will also provide that 7GC pay certain expenses of the electing Holders relating to such registrations and indemnify them against certain
liabilities that may arise under the Securities Act.
The foregoing
description of the Registration Rights Agreement is not complete and is qualified in its entirety by reference to the form of Registration
Rights Agreement, a form of which is attached as Exhibit B to the Merger Agreement, which is filed as Exhibit 10.3 to this Current Report
and incorporated herein by reference.
Lock-up Agreement
In connection
with the execution of the Merger Agreement, 7GC and certain Pre-Closing Holders have agreed to enter into a lock-up agreement (the “Lock-up
Agreement”) at the time of the Closing. The Lock-up Agreement will prohibit certain stockholders of 7GC from selling, transferring
or otherwise disposing of any 7GC New Class A Shares or 7GC New Class B Shares held by such stockholders until 180 days after the Closing.
The foregoing
description of the Lock-up Agreement is not complete and is qualified in its entirety by reference to the form of Lock-up Agreement, a
form of which is attached as Exhibit C to the Merger Agreement, which is filed as Exhibit 10.4 to this Current Report and incorporated
herein by reference.
